Recent News
On March 23, 2026 the company confirmed ongoing discussions with Puig regarding a potential combination of businesses. On May 7, 2026 the company set aside approximately $180 million related to a legal settlement in the context of that corporate process. Reports on May 1, 2026 noted an elevated headcount reduction plan, with the company indicating the workforce adjustment will be completed during 2026. The company also disclosed a minority investment in a premium clinical skin-care brand in the period.
Technical Analysis
Directional indicators show emerging but bearish pressure: ADX at 23.29 indicates an emerging trend while DI+ peaked and reversed and DI- dipped then reversed; that combination signals directional control has shifted toward sellers, increasing near-term downside vulnerability against an already over-valued classification.
Momentum measures conflict: MACD currently sits at 0.55 with the signal at 0.23, so MACD remains above the signal line (a short-term bullish crossover), yet the MACD trend shows a peak-and-reversal, indicating momentum has begun to roll over. That divergence implies any short-term bullish cross may lack follow-through if MACD momentum continues to decline.
MRO reads -1.92, indicating price sits below the internal target and therefore carries potential upside pressure; however the negative MRO sits close to zero, which implies only modest targeting force rather than strong mean-reversion fuel for the stock.
RSI at 46.95 with a peak-and-reversal trend points to declining relative-strength momentum rather than oversold conditions; price sits near the lower Bollinger band (1x lower = $78.07), which limits near-term downside but does not confirm renewed buying conviction.
Price structure favors a cautious bias: the close at $80.01 trades below the 200-day average ($93.72) and below the 20-day average ($81.78) while sitting slightly above the 50-day average ($78.94). Ichimoku components (Tenkan $81.56, Senkou A $83.56, Senkou B $93.93) keep price beneath the cloud, reinforcing a technical disadvantage versus longer-term trend. Together these signals point to choppy, range-bound action with downside skew unless directional momentum reverses decisively.
Fundamental Analysis
Recent reported results (date of report 2026-05-01) show EPS of $0.91 versus an estimate of $0.65, an EPS surprise of +40.0%. Revenue totaled $4,229,000,000 and net income amounted to $162,000,000 for the period indicated in filings.
Profitability: operating margin equals 14.377% and EBIT margin equals 9.884%. EBIT margin improved 76.44% quarter-over-quarter but contracted -170.67% year-over-year; the current EBIT margin sits above the industry peer mean of 5.174% and above the industry peer median of -0.92%. Those margin levels support an ability to generate operating profitably above the sector average, even as YoY comparatives show large percentage movement driven by prior-period baselines.
Cash flow and liquidity show strengths: operating cash flow reached $1,125,000,000 with free cash flow of $1,017,000,000, producing a free cash flow yield near 2.63% and a cash conversion ratio of 2.24. The cash balance equals $3,082,000,000 and cash plus short-term investments match that amount, while the cash conversion cycle at ~108 days sits inside the industry peer range midpoint, indicating working capital remains a material operational lever.
Capital structure and valuation multipliers diverge: debt-to-equity stands at 2.329 (substantially above the industry peer mean of 1.579), net debt equals $4,240,000,000, and enterprise multiple equals 73.06. Market multiples read as a trailing PE of ~120.0 and a forward PE of ~129.6, with a price-to-book of 9.58—each metric signals a pronounced premium relative to typical peer multiples and contributes to the current classification that WMDST values the stock as over-valued. Dividend payout equals $0.35392 per share annualized with a yield near 0.33% and dividend coverage of 1.27x, reflecting a payout that remains funded but not a primary value driver.
QoQ and YoY dynamics: revenue growth stands +21.49% overall, revenue growth QoQ accelerated ~947.17% (driven by seasonal/period effects in the reported series) and revenue growth YoY sits +12.32%; earnings growth shows QoQ weakness (-30.30%) and YoY contraction of -48.05%, indicating mixed operational leverage even as top-line expands.
Brief valuation discussion: WMDST values the stock as over-valued based on elevated market multiples (PE ~120, forward PE ~129.6, P/B ~9.58) and a high enterprise multiple that outpaces normalized free cash flow yield. Cash-flow generation remains healthy, but leverage and premium multiples constrain upside absent clearer margin expansion or decisive corporate outcomes from merger-related actions.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-05-01 |
| NEXT REPORT DATE: | 2026-07-31 |
| CASH FLOW | Begin Period Cash Flow | $ 2.2 B |
| Operating Cash Flow | $ 1.1 B | |
| Capital Expenditures | $ -108.00 M | |
| Change In Working Capital | $ 611.0 M | |
| Dividends Paid | $ -128.00 M | |
| Cash Flow Delta | $ 863.0 M | |
| End Period Cash Flow | $ 3.1 B | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 4.2 B | |
| Forward Revenue | $ 1.9 B | |
| COSTS | ||
| Cost Of Revenue | $ 994.0 M | |
| Depreciation | $ 197.0 M | |
| Depreciation and Amortization | $ 197.0 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 3.6 B | |
| PROFITABILITY | ||
| Gross Profit | $ 3.2 B | |
| EBITDA | $ 615.0 M | |
| EBIT | $ 418.0 M | |
| Operating Income | $ 608.0 M | |
| Interest Income | $ 21.0 M | |
| Interest Expense | $ 85.0 M | |
| Net Interest Income | $ -64.00 M | |
| Income Before Tax | $ 333.0 M | |
| Tax Provision | $ 171.0 M | |
| Tax Rate | 21.0 % | |
| Net Income | $ 162.0 M | |
| Net Income From Continuing Operations | $ 162.0 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.65 | |
| EPS Actual | $ 0.91 | |
| EPS Difference | $ 0.26 | |
| EPS Surprise | 40.0 % | |
| Forward EPS | $ 0.79 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 19.6 B | |
| Intangible Assets | $ 5.8 B | |
| Net Tangible Assets | $ -1.80 B | |
| Total Current Assets | $ 7.2 B | |
| Cash and Short-Term Investments | $ 3.1 B | |
| Cash | $ 3.1 B | |
| Net Receivables | $ 1.7 B | |
| Inventory | $ 1.9 B | |
| Long-Term Investments | $ 1.8 B | |
| LIABILITIES | ||
| Accounts Payable | $ 1.3 B | |
| Short-Term Debt | $ 3.0 M | |
| Total Current Liabilities | $ 5.3 B | |
| Net Debt | $ 4.2 B | |
| Total Debt | $ 9.4 B | |
| Total Liabilities | $ 15.6 B | |
| EQUITY | ||
| Total Equity | $ 4.0 B | |
| Retained Earnings | $ 11.6 B | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 11.15 | |
| Shares Outstanding | 361.660 M | |
| Revenue Per-Share | $ 11.69 | |
| VALUATION | Market Capitalization | $ 38.6 B |
| Enterprise Value | $ 44.9 B | |
| Enterprise Multiple | 73.06 | |
| Enterprise Multiple QoQ | -27.721 % | |
| Enterprise Multiple YoY | -200.458 % | |
| Enterprise Multiple IPRWA | EL: 73.06 high: 69.88 mean: 50.457 median: 50.244 low: -84.675 |
|
| EV/R | 10.625 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 4.871 | |
| Asset To Liability | 1.258 | |
| Debt To Capital | 0.7 | |
| Debt To Assets | 0.478 | |
| Debt To Assets QoQ | -1.887 % | |
| Debt To Assets YoY | 239025.0 % | |
| Debt To Assets IPRWA | high: 0.784 EL: 0.478 median: 0.392 mean: 0.369 low: 0.026 |
|
| Debt To Equity | 2.329 | |
| Debt To Equity QoQ | -3.826 % | |
| Debt To Equity YoY | 242551.042 % | |
| Debt To Equity IPRWA | EL: 2.329 high: 1.777 median: 1.777 mean: 1.579 low: 0.037 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 9.582 | |
| Price To Book QoQ | 13.901 % | |
| Price To Book YoY | 41.379 % | |
| Price To Book IPRWA | EL: 9.582 high: 4.538 median: 3.074 mean: 2.311 low: -3.161 |
|
| Price To Earnings (P/E) | 119.995 | |
| Price To Earnings QoQ | -57.715 % | |
| Price To Earnings YoY | -5.289 % | |
| Price To Earnings IPRWA | high: 257.881 EL: 119.995 median: 55.735 mean: 45.293 low: -117.686 |
|
| PE/G Ratio | 0.674 | |
| Price To Sales (P/S) | 9.133 | |
| Price To Sales QoQ | -2.847 % | |
| Price To Sales YoY | 29.426 % | |
| Price To Sales IPRWA | high: 10.77 EL: 9.133 median: 6.708 mean: 6.627 low: 0.542 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 129.6 | |
| Forward PE/G | 0.728 | |
| Forward P/S | 21.694 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 5.322 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.217 | |
| Asset Turnover Ratio QoQ | 22.292 % | |
| Asset Turnover Ratio YoY | 11.352 % | |
| Asset Turnover Ratio IPRWA | high: 0.833 mean: 0.264 median: 0.262 EL: 0.217 low: 0.082 |
|
| Receivables Turnover | 2.389 | |
| Receivables Turnover Ratio QoQ | 17.131 % | |
| Receivables Turnover Ratio YoY | 7.021 % | |
| Receivables Turnover Ratio IPRWA | high: 20.906 mean: 4.653 median: 2.898 EL: 2.389 low: 1.456 |
|
| Inventory Turnover | 0.502 | |
| Inventory Turnover Ratio QoQ | 12.078 % | |
| Inventory Turnover Ratio YoY | 11.741 % | |
| Inventory Turnover Ratio IPRWA | high: 1.117 mean: 0.65 median: 0.623 EL: 0.502 low: 0.502 |
|
| Days Sales Outstanding (DSO) | 38.202 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 107.501 | |
| Cash Conversion Cycle Days QoQ | -1.594 % | |
| Cash Conversion Cycle Days YoY | -22.479 % | |
| Cash Conversion Cycle Days IPRWA | high: 169.082 mean: 144.038 median: 139.284 EL: 107.501 low: 85.659 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 2.241 | |
| CapEx To Revenue | -0.026 | |
| CapEx To Depreciation | -0.548 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 11.3 B | |
| Net Invested Capital | $ 11.4 B | |
| Invested Capital | $ 11.4 B | |
| Net Tangible Assets | $ -1.80 B | |
| Net Working Capital | $ 1.9 B | |
| LIQUIDITY | ||
| Cash Ratio | 0.585 | |
| Current Ratio | 1.358 | |
| Current Ratio QoQ | 2.811 % | |
| Current Ratio YoY | -0.927 % | |
| Current Ratio IPRWA | high: 3.983 EL: 1.358 mean: 1.096 low: 0.788 median: 0.788 |
|
| Quick Ratio | 0.998 | |
| Quick Ratio QoQ | 9.098 % | |
| Quick Ratio YoY | 2.643 % | |
| Quick Ratio IPRWA | high: 2.804 EL: 0.998 mean: 0.812 median: 0.601 low: 0.517 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 15.268 | |
| Cost Of Debt | 0.714 % | |
| Interest Coverage Ratio | 4.918 | |
| Interest Coverage Ratio QoQ | 116.881 % | |
| Interest Coverage Ratio YoY | -179.034 % | |
| Interest Coverage Ratio IPRWA | high: 6.792 EL: 4.918 mean: 1.343 median: -1.702 low: -22.47 |
|
| Operating Cash Flow Ratio | 0.137 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 125.456 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | 1.266 | |
| Dividend Payout Ratio | 0.79 | |
| Dividend Rate | $ 0.35 | |
| Dividend Yield | 0.003 | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 1.578 % | |
| Revenue Growth | 21.488 % | |
| Revenue Growth QoQ | 947.173 % | |
| Revenue Growth YoY | 12.32 % | |
| Revenue Growth IPRWA | high: 100.0 % median: 100.0 % mean: 87.878 % EL: 21.488 % low: -21.296 % |
|
| Earnings Growth | 178.125 % | |
| Earnings Growth QoQ | -30.299 % | |
| Earnings Growth YoY | -48.047 % | |
| Earnings Growth IPRWA | EL: 178.125 % high: 100.0 % median: 82.353 % mean: 53.219 % low: -88.889 % |
|
| MARGINS | ||
| Gross Margin | 76.496 % | |
| Gross Margin QoQ | 4.261 % | |
| Gross Margin YoY | 0.522 % | |
| Gross Margin IPRWA | high: 78.157 % EL: 76.496 % median: 70.989 % mean: 69.41 % low: 7.159 % |
|
| EBIT Margin | 9.884 % | |
| EBIT Margin QoQ | 76.437 % | |
| EBIT Margin YoY | -170.671 % | |
| EBIT Margin IPRWA | high: 25.573 % EL: 9.884 % mean: 5.174 % median: -0.92 % low: -22.729 % |
|
| Return On Sales (ROS) | 14.377 % | |
| Return On Sales QoQ | 93.969 % | |
| Return On Sales YoY | -202.796 % | |
| Return On Sales IPRWA | high: 29.103 % EL: 14.377 % mean: 7.807 % median: 7.779 % low: -22.729 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 1.0 B | |
| Free Cash Flow Yield | 2.633 % | |
| Free Cash Flow Yield QoQ | -297.673 % | |
| Free Cash Flow Yield YoY | -19.578 % | |
| Free Cash Flow Yield IPRWA | high: 17.331 % mean: 3.933 % EL: 2.633 % median: 2.503 % low: -15.631 % |
|
| Free Cash Growth | -333.257 % | |
| Free Cash Growth QoQ | 58.197 % | |
| Free Cash Growth YoY | 55.686 % | |
| Free Cash Growth IPRWA | high: 301.254 % mean: 64.971 % median: 35.886 % EL: -333.257 % low: -395.699 % |
|
| Free Cash To Net Income | 6.278 | |
| Cash Flow Margin | 17.12 % | |
| Cash Flow To Earnings | 4.469 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.04 | |
| Return On Assets (ROA) | 0.832 % | |
| Return On Assets QoQ | 246.667 % | |
| Return On Assets YoY | -128.959 % | |
| Return On Assets IPRWA | high: 5.137 % EL: 0.832 % mean: 0.709 % median: 0.205 % low: -2.55 % |
|
| Return On Capital Employed (ROCE) | 2.91 % | |
| Return On Equity (ROE) | 0.04 | |
| Return On Equity QoQ | 232.699 % | |
| Return On Equity YoY | -128.399 % | |
| Return On Equity IPRWA | high: 0.058 EL: 0.04 mean: 0.006 median: 0.003 low: -0.139 |
|
| DuPont ROE | 4.091 % | |
| Return On Invested Capital (ROIC) | 2.909 % | |
| Return On Invested Capital QoQ | 111.718 % | |
| Return On Invested Capital YoY | -85.228 % | |
| Return On Invested Capital IPRWA | high: 5.448 % EL: 2.909 % mean: 0.822 % median: -0.289 % low: -9.317 % |
|